ANI Pharmaceuticals amends 2022 stock incentive plan effective May 21, 2026
ANI Pharmaceuticals restated its 2022 Stock Incentive Plan for the third time, updating equity compensation terms and definitions. The amendment affects employee incentive structures and equity participation mechanisms for the company's workforce.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day